Can a light device replace steroid sprays for hay fever?

NCT ID NCT05919316

Completed Symptom relief Sponsor: National University of Malaysia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a home-use light device (rhinophototherapy) can reduce nasal inflammation and allergy symptoms as well as a standard steroid spray. Thirty-five adults with allergic rhinitis used either the light device for 4.5 minutes three times daily or a steroid spray once daily for two weeks. Researchers measured symptom scores, nasal airflow, and looked at tissue samples for inflammation and damage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: rhinophototherapy (light device) and mometasone furoate nasal spray (steroid)
What this could lead to: If it works, this could offer a drug-free option for managing allergic rhinitis symptoms at home.
What could go wrong: This is a small, completed trial with only 35 participants, so results may not apply to everyone. The device requires daily use and may not be more effective than standard sprays.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

allergic rhinitis Rhinitis, Allergic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALLERGIC RHINITIS

Contacts and locations

Locations

Otorhinolaryngology Department, Head and Neck Surgery, Faculty of Medicine, UKM Medical Centre, Jalan Yaacob Latif, Bandar Tun Razak, Cheras

Kuala Lumpur, Cheras, 56000, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.